STAT5 is a potent negative regulator of TFH cell differentiation - PubMed (original) (raw)
STAT5 is a potent negative regulator of TFH cell differentiation
Robert J Johnston et al. J Exp Med. 2012.
Abstract
Follicular helper T cells (T(FH) cells) constitute the CD4(+) T cell subset that is specialized to provide help to germinal center (GC) B cells and, consequently, mediate the development of long-lived humoral immunity. T(FH) cell differentiation is driven by the transcription factor Bcl6, and recent studies have identified cytokine and cell-cell signals that drive Bcl6 expression. However, although T(FH) dysregulation is associated with several major autoimmune diseases, the mechanisms underlying the negative regulation of T(FH) cell differentiation are poorly understood. In this study, we show that STAT5 inhibits T(FH) cell differentiation and function. Constitutive STAT5 signaling in activated CD4(+) T cells selectively blocked T(FH) cell differentiation and GCs, and IL-2 signaling was a primary inducer of this pathway. Conversely, STAT5-deficient CD4(+) T cells (mature STAT5(fl/fl) CD4(+) T cells transduced with a Cre-expressing vector) rapidly up-regulated Bcl6 expression and preferentially differentiated into T(FH) cells during T cell priming in vivo. STAT5 signaling failed to inhibit T(FH) cell differentiation in the absence of the transcription factor Blimp-1, a direct repressor of Bcl6 expression and T(FH) cell differentiation. These results demonstrate that IL-2, STAT5, and Blimp-1 collaborate to negatively regulate T(FH) cell differentiation.
Figures
Figure 1.
STAT5 signaling selectively inhibits TFH cell differentiation and function. CD45.1+ SMARTA TCR transgenic (SM) CD4+ T cells were transduced with RVs expressing GFP and WT STAT5b (STAT5-WT), GFP and a constitutively active form of STAT5b (STAT5-CA), or only GFP (GFP). (A) Representative histograms of phospho-STAT5 levels in transduced SM cells (GFP+), without stimulation (left) or after stimulation with IL-2 (right). Phospho-STAT5 MFIs are indicated. Data are representative of two independent experiments. (B–F) Transduced SM cells (those expressing GFP) were adoptively transferred into C57BL/6J mice that were subsequently infected with LCMV (see Materials and methods). Splenocytes were analyzed 8 d after infection. Data are a composite of four (B–D) or two (E and F) independent experiments and total n = 11–16/group (B–D) or 4/group (E and F). (B) Quantitation of SM cells as a percentage of all CD4+ T cells. (C) Representative FACS plots gated on SM cells (CD4+ CD45.1+), with TFH cells (SLAMlow CXCR5high) boxed. Quantitation of SM TFH cells as a percentage of all SM cells. GFP versus STAT5-WT: ***, P = 0.0002; GFP versus STAT5-CA: ***, P < 0.0001; STAT5-WT versus STAT5-CA: ***, P < 0.0001. (D) Representative FACS plots gated on B cells (B220+), with GC B cells (Fas+ GL7+) circled. Quantitation of GC B cells as a percentage of all B cells. Uninfected C57BL/6J mice (naive) are also shown. ***, P < 0.0001. (E) Representative histograms of FoxP3 expression in SM cells and in total CD4+ T cells from an uninfected C57BL/6J mouse (naive). Quantitation of FoxP3 MFI, with natural Treg cells (nTreg; CD4+ CD25+ FoxP3+) from a naive C57BL/6J mouse included as a control. (F) Quantitation of the percentage of SM cells that produced IFN-γ after PMA/ionomycin stimulation in vitro. Error bars depict the standard error of the mean.
Figure 2.
Lack of STAT5 signaling enhances TFH cell differentiation. STAT5fl/fl SM cells were transduced with an RV expressing Cre recombinase (Cre) or were not transduced but treated similarly (control). (A) Representative histograms of phospho-STAT5 levels in SM cells, with and without IL-2 stimulation. The percentage of cells that was phospho-STAT5+ is indicated. (B–J) Cre+ and control SM cells were adoptively transferred into C57BL/6J mice that were subsequently infected with LCMV. Splenocytes were analyzed 8 (B–F) or 4 (G–J) d after infection. Data are a composite of two independent experiments, and n = 8/group. (B) Quantitation of SM cells as a percentage of all CD4+ T cells. (C) Representative histograms gated on SM cells or on CD4+ T cells from an uninfected C57BL/6J mouse (naive). (D) Representative FACS plots gated on SM cells, with TFH cells (SLAMlow CXCR5high) boxed. Quantitation of SM TFH cells as a percentage of total SM cells. ***, P < 0.0001. (E) Representative FACS plots gated on SM cells, with GC TFH cells (CXCR5high GL7high) boxed. Quantitation of SM GC TFH cells as a percentage of total SM cells. **, P = 0.01. (F) IL-21 production by SM cells after PMA/ionomycin stimulation in vitro. Quantitation of IL-21+ SM cells as a percentage of total SM cells. (G) Quantitation of SM cells as a percentage of total CD4+ T cells. (H) Representative histograms of Bcl6 expression, gated on SM cells or on CD4+ T cells from an uninfected C57BL/6J mouse (naive). Quantitation of SM cell Bcl6 MFI. **, P = 0.0012. (I) Representative FACS plots gated on SM cells, with TFH (Bcl6high CXCR5high) boxed. Quantitation of SM TFH cells as a percentage of all SM cells. ***, P < 0.0001. (J) Representative FACS plots gated on SM cells, with non-TFH cells (CD25high CXCR5low) boxed. Quantitation of non-TFH SM cells as a percentage of total SM cells. ***, P < 0.0001. Error bars depict the standard error of the mean.
Figure 3.
IL-2 signaling inhibits TFH cell differentiation during T cell priming. (A–D) WT and CD25+/− SM CD4+ T cells were adoptively transferred into C57BL/6J mice that were infected with LCMV 1 d later. Splenocytes were analyzed 2 (A–C) or 3 (D) d after infection. Data are representative of two independent experiments, and n = 5/group. (A) Quantitation of SM cells as a percentage of total CD4+ T cells. (B) Quantitation of SM cell CD69 and CD25 MFI. ***, P < 0.0001. (C) Representative FACS plots gated on SM cells, with TFH-committed cells (CD25low Bcl6high) boxed. Quantitation of TFH-committed SM cells as a percentage of total SM cells. ***, P < 0.0001. (D) Representative FACS plots gated on SM cells, with TFH-committed cells (Bcl6high CXCR5high) boxed. Quantitation of TFH-committed SM cells as a percentage of total SM cells. **, P = 0.01. (E and F) WT SM CD4+ T cells were adoptively transferred into C57BL/6J mice. Host mice were treated with anti–IL-2 neutralizing antibodies or isotype-matched control antibodies and infected with LCMV 1 d later. Splenocytes were analyzed 2 d after infection. Data are representative of two independent experiments, and n = 5/group. (E) Quantitation of SM cells as a percentage of total CD4+ T cells. (F) Representative FACS plots gated on SM cells, with TFH-committed cells (CD25low Bcl6high) boxed. Quantitation of TFH-committed SM cells as a percentage of total SM cells. ***, P = 0.001. Error bars depict the standard error of the mean.
Figure 4.
STAT5 inhibition of TFH cell differentiation is mediated by Blimp-1. Prdm1fl/fl SM cells were transduced with STAT5-CA RV and/or with a variant of Cre RV expressing the fluorescent protein mAmetrine or were not transduced but treated similarly (control). Data are a composite of three (A–C) or two (D) independent experiments, and n = 11–12/group (A–C) or 8/group (D). (A) Representative FACS plot gated on viable (7AADlow) cells, with untransduced, singly transduced, and cotransduced cells boxed. (B–D) Transduced or control SM cells were adoptively transferred into C57BL/6J mice that were infected with LCMV 3–5 d later. Splenocytes were analyzed 8 d after infection. (B) Quantitation of SM cells as a percentage of total CD4+ T cells. (C) Representative FACS plots gated on SM cells, with TFH cells (SLAMlow CXCR5high) boxed. Quantitation of SM TFH cells as a percentage of total SM cells. Data have been normalized so that the mean control SM TFH percentage for each experiment is 100%. ***, P < 0.0001. (D) Representative FACS plots gated on SM cells, with GC TFH cells (GL7high CXCR5high) boxed. Quantitation of SM GC TFH cells as a percentage of total SM cells. Data have been normalized so that the mean control SM GC TFH percentage for each experiment is 100%. *, P = 0.0330; ***, P < 0.0001. Error bars depict the standard error of the mean.
Comment in
- STAT5 reins in the follicular helpers.
Bordon Y. Bordon Y. Nat Rev Immunol. 2012 Feb 3;12(3):152. doi: 10.1038/nri3170. Nat Rev Immunol. 2012. PMID: 22301851 No abstract available.
Similar articles
- Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation.
Johnston RJ, Poholek AC, DiToro D, Yusuf I, Eto D, Barnett B, Dent AL, Craft J, Crotty S. Johnston RJ, et al. Science. 2009 Aug 21;325(5943):1006-10. doi: 10.1126/science.1175870. Epub 2009 Jul 16. Science. 2009. PMID: 19608860 Free PMC article. - Genome-wide Analysis Identifies Bcl6-Controlled Regulatory Networks during T Follicular Helper Cell Differentiation.
Liu X, Lu H, Chen T, Nallaparaju KC, Yan X, Tanaka S, Ichiyama K, Zhang X, Zhang L, Wen X, Tian Q, Bian XW, Jin W, Wei L, Dong C. Liu X, et al. Cell Rep. 2016 Feb 23;14(7):1735-1747. doi: 10.1016/j.celrep.2016.01.038. Epub 2016 Feb 11. Cell Rep. 2016. PMID: 26876184 Free PMC article. - Bcl6 middle domain repressor function is required for T follicular helper cell differentiation and utilizes the corepressor MTA3.
Nance JP, Bélanger S, Johnston RJ, Hu JK, Takemori T, Crotty S. Nance JP, et al. Proc Natl Acad Sci U S A. 2015 Oct 27;112(43):13324-9. doi: 10.1073/pnas.1507312112. Epub 2015 Oct 12. Proc Natl Acad Sci U S A. 2015. PMID: 26460037 Free PMC article. - Follicular helper CD4 T cells (TFH).
Crotty S. Crotty S. Annu Rev Immunol. 2011;29:621-63. doi: 10.1146/annurev-immunol-031210-101400. Annu Rev Immunol. 2011. PMID: 21314428 Review. - Signals that influence T follicular helper cell differentiation and function.
Linterman MA, Vinuesa CG. Linterman MA, et al. Semin Immunopathol. 2010 Jun;32(2):183-96. doi: 10.1007/s00281-009-0194-z. Epub 2010 Jan 27. Semin Immunopathol. 2010. PMID: 20107805 Review.
Cited by
- Spatial microniches of IL-2 combine with IL-10 to drive lung migratory TH2 cells in response to inhaled allergen.
He K, Xiao H, MacDonald WA, Mehta I, Kishore A, Vincent A, Xu Z, Ray A, Chen W, Weaver CT, Lambrecht BN, Das J, Poholek AC. He K, et al. Nat Immunol. 2024 Oct 11. doi: 10.1038/s41590-024-01986-8. Online ahead of print. Nat Immunol. 2024. PMID: 39394532 - Role of TGFβ-producing regulatory T cells in scleroderma and end-stage organ failure.
Lu KC, Tsai KW, Hu WC. Lu KC, et al. Heliyon. 2024 Aug 2;10(15):e35590. doi: 10.1016/j.heliyon.2024.e35590. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170360 Free PMC article. Review. - Transcriptional regulation of Tfh dynamics and the formation of immunological synapses.
Kim YJ, Choi J, Choi YS. Kim YJ, et al. Exp Mol Med. 2024 Jun;56(6):1365-1372. doi: 10.1038/s12276-024-01254-7. Epub 2024 Jun 3. Exp Mol Med. 2024. PMID: 38825646 Free PMC article. Review. - Concomitant use of interleukin-2 and tacrolimus suppresses follicular helper T cell proportion and exerts therapeutic effect against lupus nephritis in systemic lupus erythematosus-like chronic graft versus host disease.
Nasa Y, Satake A, Tsuji R, Saito R, Tsubokura Y, Yoshimura H, Ito T. Nasa Y, et al. Front Immunol. 2024 Apr 11;15:1326066. doi: 10.3389/fimmu.2024.1326066. eCollection 2024. Front Immunol. 2024. PMID: 38665907 Free PMC article. - Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer.
Shouse AN, LaPorte KM, Malek TR. Shouse AN, et al. Immunity. 2024 Mar 12;57(3):414-428. doi: 10.1016/j.immuni.2024.02.001. Immunity. 2024. PMID: 38479359 Review.
References
- Akiba H., Takeda K., Kojima Y., Usui Y., Harada N., Yamazaki T., Ma J., Tezuka K., Yagita H., Okumura K. 2005. The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo. J. Immunol. 175:2340–2348 - PubMed
- Burchill M.A., Yang J., Vogtenhuber C., Blazar B.R., Farrar M.A. 2007. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J. Immunol. 178:280–290 - PubMed
- Choi Y.S., Kageyama R., Eto D., Escobar T.C., Johnston R.J., Monticelli L., Lao C., Crotty S. 2011. ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity. 34:932–946 10.1016/j.immuni.2011.03.023 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous